These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 33601193)
21. Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working Group. Ogdie A; de Wit M; Callis Duffin K; Campbell W; Chau J; Coates LC; Eder L; Elmamoun M; FitzGerald O; Gladman DD; Goel N; James J; Kalyoncu U; Latella J; Lindsay C; Mease PJ; O'Sullivan D; Steinkoenig I; Strand V; Tillett W; Orbai AM J Rheumatol; 2017 May; 44(5):697-700. PubMed ID: 28461531 [TBL] [Abstract][Full Text] [Related]
22. Axial Disease in Psoriatic Arthritis study: defining the clinical and radiographic phenotype of psoriatic spondyloarthritis. Jadon DR; Sengupta R; Nightingale A; Lindsay M; Korendowych E; Robinson G; Jobling A; Shaddick G; Bi J; Winchester R; Giles JT; McHugh NJ Ann Rheum Dis; 2017 Apr; 76(4):701-707. PubMed ID: 27913376 [TBL] [Abstract][Full Text] [Related]
23. Measurement properties of instruments assessing psoriatic arthritis symptoms for psoriasis clinical trials: a systematic literature review. Perez-Chada LM; Balak D; Cohen JM; Ogdie A; Merola JF; Gottlieb AB Expert Rev Clin Immunol; 2020 Mar; 16(3):267-283. PubMed ID: 32037912 [No Abstract] [Full Text] [Related]
24. The OMERACT MRI in Arthritis Working Group - Update on Status and Future Research Priorities. Østergaard M; Bird P; Gandjbakhch F; Eshed I; Haugen IK; Haavardsholm EA; Lillegraven S; Foltz V; Glinatsi D; Peterfy C; Ejbjerg B; Bøyesen P; Mease PJ; Hermann KG; Emery P; Genant HK; Conaghan PG J Rheumatol; 2015 Dec; 42(12):2470-2. PubMed ID: 25684771 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of radiographic progression across levels of composite index-defined disease activity in patients with active psoriatic arthritis treated with intravenous golimumab: results from a phase-3, double-blind, placebo-controlled trial. Mease P; Husni ME; Kafka S; Chakravarty SD; Harrison DD; Lo KH; Xu S; Hsia EC; Kavanaugh A Arthritis Res Ther; 2020 Mar; 22(1):43. PubMed ID: 32143685 [TBL] [Abstract][Full Text] [Related]
27. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis. Coates LC; FitzGerald O; Merola JF; Smolen J; van Mens LJJ; Bertheussen H; Boehncke WH; Callis Duffin K; Campbell W; de Wit M; Gladman D; Gottlieb A; James J; Kavanaugh A; Kristensen LE; Kvien TK; Luger T; McHugh N; Mease P; Nash P; Ogdie A; Rosen CF; Strand V; Tillett W; Veale DJ; Helliwell PS Arthritis Rheumatol; 2018 Mar; 70(3):345-355. PubMed ID: 29193765 [TBL] [Abstract][Full Text] [Related]
28. Investigator and Patient Global Assessment Measures for Psoriasis Clinical Trials: A Systematic Review on Measurement Properties from the International Dermatology Outcome Measures (IDEOM) Initiative. Perez-Chada LM; Salame NF; Ford AR; Duffin KC; Garg A; Gottlieb AB; Latella J; Merola JF; Armstrong AW Am J Clin Dermatol; 2020 Jun; 21(3):323-338. PubMed ID: 31950353 [TBL] [Abstract][Full Text] [Related]
29. Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: Results from the induction and maintenance psoriatic arthritis clinical trial 2. van der Heijde D; Kavanaugh A; Gladman DD; Antoni C; Krueger GG; Guzzo C; Zhou B; Dooley LT; de Vlam K; Geusens P; Birbara C; Halter D; Beutler A Arthritis Rheum; 2007 Aug; 56(8):2698-707. PubMed ID: 17665424 [TBL] [Abstract][Full Text] [Related]
30. The smallest detectable difference and sensitivity to change of magnetic resonance imaging and radiographic scoring of structural joint damage in rheumatoid arthritis finger, wrist, and toe joints: a comparison of the OMERACT rheumatoid arthritis magnetic resonance imaging score applied to different joint combinations and the Sharp/van der Heijde radiographic score. Ejbjerg BJ; Vestergaard A; Jacobsen S; Thomsen HS; Østergaard M Arthritis Rheum; 2005 Aug; 52(8):2300-6. PubMed ID: 16052593 [TBL] [Abstract][Full Text] [Related]
31. The GRAPPA-OMERACT Working Group: 4 Prioritized Domains for Completing the Core Outcome Measurement Set for Psoriatic Arthritis 2019 Updates. Leung YY; Tillett W; Orbai AM; Ogdie A; Eder L; Coates LC; Holland R; Antony A; Goel N; Mease PJ; Strand V; FitzGerald O; de Wit M; Lindsay CA; Callis Duffin K; Gladman DD J Rheumatol Suppl; 2020 Jun; 96():46-49. PubMed ID: 32482768 [TBL] [Abstract][Full Text] [Related]
32. Enhanced Patient Involvement and the Need to Revise the Core Set - Report from the Psoriatic Arthritis Working Group at OMERACT 2014. Tillett W; Eder L; Goel N; De Wit M; Gladman DD; FitzGerald O; Campbell W; Helliwell PS; Gossec L; Orbai AM; Ogdie A; Strand V; McHugh NJ; Mease PJ J Rheumatol; 2015 Nov; 42(11):2198-203. PubMed ID: 25934828 [TBL] [Abstract][Full Text] [Related]
33. Development of a disease severity and responder index for psoriatic arthritis (PsA)--report of the OMERACT 10 PsA special interest group. Coates LC; Mumtaz A; Helliwell PS; Mease PJ; Callis-Duffin K; Krueger GG; McHugh NJ; Strand V; Gladman DD; FitzGerald O J Rheumatol; 2011 Jul; 38(7):1496-501. PubMed ID: 21724722 [TBL] [Abstract][Full Text] [Related]
34. The evolution of instrument selection for inclusion in core outcome sets at OMERACT: Filter 2.2. Maxwell LJ; Beaton DE; Boers M; D'Agostino MA; Conaghan PG; Grosskleg S; Shea BJ; Bingham Iii CO; Boonen A; Christensen R; Choy E; Doria AS; Hill CL; Hofstetter C; Kroon FP; Leung YY; Mackie S; Meara A; Touma Z; Tugwell P; Wells GA Semin Arthritis Rheum; 2021 Dec; 51(6):1320-1330. PubMed ID: 34544617 [TBL] [Abstract][Full Text] [Related]
35. Determinants of radiographic progression in early psoriatic arthritis: insights from a real-world cohort. Koc GH; Kok MR; do Rosario Y; Luime JJ; Tchetverikov I; Kasiem FR; Korswagen LA; Bijsterbosch J; Goekoop-Ruiterman YPM; van Oosterhout M; Baudoin P; Kok P; Dolhain RJEM; Vis M RMD Open; 2024 May; 10(2):. PubMed ID: 38796181 [TBL] [Abstract][Full Text] [Related]
36. Repair of radiographic joint damage following treatment with etanercept in psoriatic arthritis is demonstrable by 3 radiographic methods. Eder L; Chandran V; Gladman DD J Rheumatol; 2011 Jun; 38(6):1066-70. PubMed ID: 21324963 [TBL] [Abstract][Full Text] [Related]
37. The radiological assessment of axial involvement in psoriatic arthritis: a validation study of the BASRI total and the modified SASSS scoring methods. Lubrano E; Marchesoni A; Olivieri I; D'Angelo S; Spadaro A; Parsons WJ; Cauli A; Salvarani C; Mathieu A; Zaccara E; Ferrara N; Helliwell PS Clin Exp Rheumatol; 2009; 27(6):977-80. PubMed ID: 20149315 [TBL] [Abstract][Full Text] [Related]
38. Effect of Secukinumab on the Different GRAPPA-OMERACT Core Domains in Psoriatic Arthritis: A Pooled Analysis of 2049 Patients. Orbai AM; McInnes IB; Coates LC; Husni ME; Gladman DD; Gossec L; Pricop L; Chambenoit O; Meng X; Mease PJ J Rheumatol; 2020 Jun; 47(6):854-864. PubMed ID: 31615919 [TBL] [Abstract][Full Text] [Related]
39. Feasibility, reliability, and sensitivity to change of four radiographic scoring methods in patients with psoriatic arthritis. Tillett W; Jadon D; Shaddick G; Robinson G; Sengupta R; Korendowych E; de Vries CS; McHugh NJ Arthritis Care Res (Hoboken); 2014 Feb; 66(2):311-7. PubMed ID: 23925955 [TBL] [Abstract][Full Text] [Related]
40. Radiographic Progression Inhibition with Intravenous Golimumab in Psoriatic Arthritis: Week 24 Results of a Phase III, Randomized, Double-blind, Placebo-controlled Trial. Kavanaugh A; Husni ME; Harrison DD; Kim L; Lo KH; Noonan L; Hsia EC J Rheumatol; 2019 Jun; 46(6):595-602. PubMed ID: 30770519 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]